SPIRIVA: cost and payments to doctors
What Medicare Part D paid pharmacies for SPIRIVA, and the payments that named it as the associated drug or biological under the Sunshine Act for program years 2019–2025.
Part D cost for SPIRIVA formulations
Medicare reports SPIRIVA under its specific formulations, which are priced separately.
- spiriva respimat$465per 30-day fill · 904,887 claims · Tiotropium Bromide
- spiriva handihaler$497per 30-day fill · 320,158 claims · Tiotropium Bromide
Paid to pharmacies by Part D plans and patients — not your cost, and not paid to the prescriber. Is this wrong?
Was your doctor paid by Boehringer Ingelheim?
Boehringer Ingelheim reported the most payments naming SPIRIVA. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $499K
- Providers
- 3,114
- Transactions
- 4,990
- Average per transaction
- $100
The per-transaction average — $100 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,114 providers the average total is $160, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Boehringer Ingelheim | $430,518 | 86.3% |
| Boehringer Ingelheim International GmbH | $51,969 | 10.4% |
| Boehringer Ingelheim Do Brasil Quimica E Farmaceutical Ltda. | $16,601 | 3.3% |
Other products from Boehringer Ingelheim
The company that reported the most payments naming SPIRIVA also reports against these.
- JARDIANCE$52,023,768
- OFEV$14,178,864
- SPIRIVA RESPIMAT$3,503,911
- SPEVIGO$3,021,755
- STIOLTO RESPIMAT$2,923,329
- TRADJENTA$1,653,735
- SYNJARDY$1,611,380
- PRADAXA$999,218
- GILOTRIF$981,921
- GLYXAMBI$537,523